Innoviva

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.

About INVA

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.

CEO

Pavel Raifeld

CEOPavel Raifeld

Employees

—

Employees—

Headquarters

Burlingame, California

HeadquartersBurlingame, California

Founded

1996

Founded1996

Employees

—

Employees—

INVA Key Statistics

Market cap

960.42M

Market cap960.42M

Price-Earnings ratio

6.96

Price-Earnings ratio6.96

Dividend yield

—

Dividend yield—

Average volume

672.15K

Average volume672.15K

High today

$15.63

High today$15.63

Low today

$15.13

Low today$15.13

Open price

$15.53

Open price$15.53

Volume

428.63K

Volume428.63K

52 Week high

$16.87

52 Week high$16.87

52 Week low

$11.40

52 Week low$11.40